These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3841602)

  • 41. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased sensitivity of ventricular myocardium to intracellular calcium-overload in Syrian cardiomyopathic hamster.
    Wiederhold KF; Nilius B
    Biomed Biochim Acta; 1986; 45(10):1333-7. PubMed ID: 3551930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines].
    Kaverina NV; Senova ZP; Lyskovzev VV; Demina LM; Grizenko AN; Skoldinov AP; Femmer K; Poppe H; Stark A; Wunderlich H
    Pharmazie; 1985 Dec; 40(12):830-2. PubMed ID: 4095141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: The antiarrhythmic activity of the prostaglandins A2, E2, and F2alpha.
    Kaiser J; Schoelkens B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R44. PubMed ID: 4276580
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-arrhythmic action of d-isocorydine hydrochloride].
    Zhao DH; Yang XM; Sheng BH
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):131-4. PubMed ID: 2946149
    [No Abstract]   [Full Text] [Related]  

  • 47. Electrophysiologic effects of exogenous phosphocreatine in cardiac tissue: potential antiarrhythmic actions.
    Rosenshtraukh LV; Witt RC; Nance PN; Rozanski GJ
    Am Heart J; 1990 Nov; 120(5):1111-9. PubMed ID: 2239663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of 3,4-dihydroxyacetophenone (DHAP) on electrical and mechanical activities in the isolated myocardium].
    Yang QF; Mu H; Fang LM
    Yao Xue Xue Bao; 1986 Jun; 21(6):466-8. PubMed ID: 3811933
    [No Abstract]   [Full Text] [Related]  

  • 49. [An electrophysiological study of the anti-arrhythmia effect of antioxidant ionol].
    Gaĭnullin RZ; Medvinskiĭ AB; Kozhokaru AF; Kukushkin NI
    Biull Eksp Biol Med; 1991 Aug; 112(8):167-9. PubMed ID: 1786379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observations on the nature of the voltage shift of antiarrhythmic drugs.
    Hondeghem LM; Ehring GR; Moyer JW
    Proc West Pharmacol Soc; 1978; 21():67-9. PubMed ID: 693542
    [No Abstract]   [Full Text] [Related]  

  • 51. [The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites].
    Rodionov AP; Zolotov NN; Lyskovtsev VV; Zalilov KIu; Poppe H
    Farmakol Toksikol; 1990; 53(3):50-1. PubMed ID: 2387383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
    Rodionov AP; Lyskovtsev VV; Ignatova NA; Tolmacheva EA; Grigor'eva EK; Belinskiaia GF; Sheĭnberg BV
    Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor based on the data from an acute drug test].
    Smerdina IS; Fomichev VI; Nesvetov VN; Gorshkov VA; Preobrazhenskiĭ DV
    Kardiologiia; 1993; 33(7):11-4, 3. PubMed ID: 8309173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmaceutical characterization and spectroscopy of Bonnecor (AWD 19-166, GS 015)].
    Mayer W; Usbeck H; Rodionov AP
    Pharmazie; 1985 Dec; 40(12):832-5. PubMed ID: 3841596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of prolyl-valine on electrical activities of rat hearts in situ and its antiarrhythmic action (author's transl)].
    Liu TF; Wei JH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Dec; 9(4):311-3. PubMed ID: 7341201
    [No Abstract]   [Full Text] [Related]  

  • 56. [An experimental study of the safety of the preparation bonnecor in trials on dogs].
    Kovalenko LP; Sorokina AV; Popova GR; Batanova OA; Liubimov BI
    Farmakol Toksikol; 1990; 53(3):54-7. PubMed ID: 2387384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A benzotriazinium salt as a potential antiarrhythmic agent [proceedings].
    French AM; Scott NC
    Br J Pharmacol; 1977 Sep; 61(1):131P-132P. PubMed ID: 912182
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacological studies on the myocardial effects of O,S-dicarbethoxythiamine (DCET).
    Ueda M
    Jpn J Pharmacol; 1966 Mar; 16(1):53-62. PubMed ID: 5297506
    [No Abstract]   [Full Text] [Related]  

  • 59. Microelectropharmacological study of prajmaline in rabbit papillary muscle.
    Virág L; Papp JG; Szekeres L
    Acta Physiol Hung; 1990; 75 Suppl():295-6. PubMed ID: 2371895
    [No Abstract]   [Full Text] [Related]  

  • 60. [The psychotropic properties of bonnecor and ethacizine].
    Voronina TA; Garibova TL; Barch R; Rostock A; Khromova IV; Artemenko GN; Zigemund K; Hoffmann V
    Farmakol Toksikol; 1990; 53(3):52-4. PubMed ID: 1974866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.